Year: 2013
Type: review
Abstract: Stimulant use disorders are an unrelenting public health concern worldwide. Agonist replacement therapy is among the most effective strategies for managing substance use disorders including nicotine and opioid dependence. The present paper reviewed clinical data from human laboratory self-administration studies and clinical trials to determine whether agonist replacement therapy is a viable strategy for managing cocaine and/or amphetamine use disorders. The extant literature suggests that agonist replacement therapy may be effective for managing stimulant use disorders, however, the clinical selection of an agonist replacement medication likely needs to be based on the pharmacological mechanism of the medication and the stimulant abused by patients. Specifically, dopamine releasers appear most effective for reducing cocaine use whereas dopamine reuptake inhibitors appear most effective for reducing amphetamine use.
Source: Current Pharmaceutical Design
Authors: William Stoops, Craig Rush
Institutions: University of Kentucky HealthCare, University of Kentucky
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Institute on Drug Abuse
Awards: Agonist Replacement Therapy for Cocaine Dependence: Identifying Novel Medications, A Human Laboratory Study to Investigate Buspirone for Cocaine Use Disorders, Agonist Replacement Therapy for Methamphetamine Dependence: Human Lab Studies, A Novel Anti Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
OpenAlex ID: W2086786948
